Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene F Schuster

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
NPJ Breast Cancer|February 13, 2021
Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®Richard Buus, Zsolt Szijgyarto, Eugene F Schuster, et al.
Ebiomedicine|July 19, 2025
Short-duration preoperative endocrine therapy alters molecular profiles to predict favourable outcome in ER+/HER2+ early breast cancer: a POETIC translational studyMilana Bergamino Sirvén, Elena López-Knowles, Xixuan Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor-positive Breast CancersMilana A Bergamino, Gabriele Morani, Joel Parker, et al.
Breast Cancer Research : BCR|September 12, 2022
Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC studyElena Lopez-Knowles, Simone Detre, Margaret Hills, et al.
Physiological Genomics|August 3, 2006
Coordinated multitissue transcriptional and plasma metabonomic profiles following acute caloric restriction in miceColin Selman, Nicola D Kerrison, Anisha Cooray, et al.
Nature Communications|July 7, 2023
Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancersEugene F Schuster, Elena Lopez-Knowles, Anastasia Alataki, et al.
Ebiomedicine|August 19, 2022
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancerMilana A Bergamino, Elena López-Knowles, Gabriele Morani, et al.
NPJ Breast Cancer|July 1, 2024
Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studiesMaggie Chon U Cheang, Mothaffar Rimawi, Stephen Johnston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2019
Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy ResistanceAlex Pearson, Paula Proszek, Javier Pascual, et al.
Nature Communications|June 29, 2023
The proteomic landscape of soft tissue sarcomasJessica Burns, Christopher P Wilding, Lukas Krasny, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
NPJ Breast Cancer|February 13, 2021
Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®Richard Buus, Zsolt Szijgyarto, Eugene F Schuster, et al.
Ebiomedicine|July 19, 2025
Short-duration preoperative endocrine therapy alters molecular profiles to predict favourable outcome in ER+/HER2+ early breast cancer: a POETIC translational studyMilana Bergamino Sirvén, Elena López-Knowles, Xixuan Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor-positive Breast CancersMilana A Bergamino, Gabriele Morani, Joel Parker, et al.
Breast Cancer Research : BCR|September 12, 2022
Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC studyElena Lopez-Knowles, Simone Detre, Margaret Hills, et al.
Physiological Genomics|August 3, 2006
Coordinated multitissue transcriptional and plasma metabonomic profiles following acute caloric restriction in miceColin Selman, Nicola D Kerrison, Anisha Cooray, et al.
Nature Communications|July 7, 2023
Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancersEugene F Schuster, Elena Lopez-Knowles, Anastasia Alataki, et al.
Ebiomedicine|August 19, 2022
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancerMilana A Bergamino, Elena López-Knowles, Gabriele Morani, et al.
NPJ Breast Cancer|July 1, 2024
Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studiesMaggie Chon U Cheang, Mothaffar Rimawi, Stephen Johnston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2019
Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy ResistanceAlex Pearson, Paula Proszek, Javier Pascual, et al.
Nature Communications|June 29, 2023
The proteomic landscape of soft tissue sarcomasJessica Burns, Christopher P Wilding, Lukas Krasny, et al.
Pageof 3